Rui Batista Selected Research

Rui Batista Research Topics

Disease

15	Neoplasms (Cancer) 10/2021 - 01/2013
8	Thyroid Neoplasms (Thyroid Cancer) 07/2020 - 01/2013
3	Papillary Thyroid Cancer 05/2018 - 08/2016
2	COVID-19 05/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2016
2	Non-Muscle Invasive Bladder Neoplasms 01/2020 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2020
2	Carcinogenesis 08/2016 - 01/2013
1	Leukemia 01/2022
1	Febrile Neutropenia 01/2022
1	Infections 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Philadelphia Chromosome 12/2021
1	Giardiasis 11/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Inflammation (Inflammations) 01/2021
1	Thyroiditis 07/2020
1	Superinfection 05/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2019
1	Chronic Disease (Chronic Diseases) 07/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Communicable Diseases (Infectious Diseases) 03/2016
1	Clostridium Infections 03/2016
1	Glioma (Gliomas) 01/2016
1	Central Serous Chorioretinopathy 12/2015
1	Tinea Capitis 01/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2007

Drug/Important Bio-Agent (IBA)

6	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 01/2013
5	Messenger RNA (mRNA)IBA 07/2020 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 12/2017 - 08/2016
2	Indicators and Reagents (Reagents)IBA 12/2016 - 05/2014
1	ChAdOx1 nCoV-19IBA 05/2022
1	VaccinesIBA 05/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	asciminibIBA 12/2021
1	ponatinibIBA 12/2021
1	Quinacrine (Mepacrine)IBA 11/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 04/2021
1	InterferonsIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	TOR Serine-Threonine KinasesIBA 05/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2018
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2018
1	somatotropin releasing hormone receptorIBA 12/2017
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 12/2017
1	Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA 12/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Biological ProductsIBA 12/2016
1	OsteopontinIBA 08/2016
1	Mineralocorticoid Receptor AntagonistsIBA 12/2015
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2015
1	Mitochondrial DNA (mtDNA)IBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2020 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
2	Transplantation 05/2019 - 03/2016
1	Fecal Microbiota Transplantation 07/2017
1	Hair Removal (Depilation) 01/2014
1	Drug Substitution 01/2007